Product ID |
Product Name |
CAS# |
Purity |
Y3291171 |
BocNH-PEG7-CH2COOH |
141282-29-3 |
97% |
Y1258118 |
Imatinib D4 |
1134803-16-9 |
99% |
Y3246005 |
Ligustrosidic acid |
96382-89-7 |
94% |
Y3294603 |
PROTAC MDM2 Degrader-1 |
2249944-98-5 |
98% |
Y3244328 |
BRD5648 |
2056261-42-6 |
99% |
Y3264326 |
1,3-dimethyl 5-(2,5-dimethyl-1H-pyrrol-1-yl)benzene-1,3-dicarboxylate |
307341-12-4 |
95% |
Y1253669 |
Tyk2-IN-7 |
1609391-90-3 |
99% |
Y1344344 |
CCT365623 hydrochloride |
2126136-98-7 |
98% |
Y3264800 |
Latinone |
79157-36-1 |
95% |
Y3307800 |
4-(Benzyloxy)-2-chloropyridin-3-amine |
1783343-14-5 |
95% |
Y3253647 |
(E)-{[(methylsulfanyl)methanethioyl]amino}(1-phenylethylidene)amine |
177540-63-5 |
100% |
Y3252581 |
CCR2 antagonist 3 |
1380100-86-6 |
99% |
Y3242724 |
trans-2-ethynylcyclohexan-1-ol |
55506-28-0 |
95% |
Y3312515 |
(R)-3,3'-Di-1-pyrenyl-1,1'-bi-2-naphthol |
1854074-51-3 |
97% |
Y1235383 |
Cesium formate hydrate |
1266615-84-2 |
97% |
Y3262368 |
Dichloro[9,9-dimethyl-4,5-bis(diphenylphosphino)xanthene]Cobalt(II) |
898807-69-7 |
98% |
Y3262221 |
Cerium(III) oxalate hydrate |
880358-87-2 |
99% |
Y1339740 |
(2-(4-Ethynylphenyl)ethene-1,1,2-triyl)tribenzene |
1225493-18-4 |
97% |
Y1235384 |
Dichloro[(oxydi-2,1-phenylene)bis[diphenylphosphine-P]]nickel |
442519-81-5 |
98% |
Y1235385 |
4',4''',4'''''-(1,3,5-Triazine-2,4,6-triyl)tris(([1,1'-biphenyl]-4-carbaldehyde)) |
1221509-80-3 |
95% |
Y1235347 |
1,1,2,2-Tetrakis(4-(1H-imidazol-1-yl)phenyl)ethene |
1477527-27-7 |
97% |
Y1265914 |
5'''-(4''-Carboxy-[1,1':4',1''-terphenyl]-4-yl)-[1,1':4',1'':4'',1''':3''',1'''':4'''',1''''':4''''',1''''''-septiphenyl]-4,4''''''-dicarboxylic acid |
1246015-42-8 |
98% |
Y1343249 |
6-[4-(diethylamino)-3-nitrophenyl]-5-methyl-2,3,4,5-tetrahydropyridazin-3-one |
328104-79-6 |
98% |
Y1265956 |
4,4'-(2,2-Diphenylethene-1,1-diyl)dibenzoic acid |
1609575-40-7 |
98% |
Y1239694 |
3,3'''-(Anthracene-9,10-diyl)bis(([1,1':3',1''-terphenyl]-4,4''-dicarboxylic acid)) |
913343-74-5 |
95% |
Y3248539 |
2-[(2E)-1,3,3-trimethyl-2,3-dihydro-1H-indol-2-ylidene]acetaldehyde |
85654-15-5 |
95% |
Y3289760 |
4,5-Diamino-2-bromobenzonitrile |
1934682-48-0 |
95% |
Y3258090 |
4-(3,5-Dimethyl-1H-1,2,4-triazol-1-yl)benzoic acid hydrochloride |
879657-96-2 |
95% |
Y1314329 |
5',5'''-Bis(4-carboxyphenyl)-5''-(4,4''-dicarboxy-[1,1':3',1''-terphenyl]-5'-yl)-[1,1':3',1'':3'',1''':3''',1''''-quinquephenyl]-4,4''''-dicarboxylic acid |
1331745-95-9 |
98% |
Y3290267 |
4-methoxy-N-[5-(thiophen-2-yl)-1,3,4-oxadiazol-2-yl]-1,3-benzothiazol-2-amine |
862974-28-5 |
97% |
Y1265958 |
4,4'-(1,4-Phenylenebis(ethyne-2,1-diyl))dibenzaldehyde |
192188-70-8 |
97% |
Y3255505 |
2-(2-methylphenoxy)-1-(1,2,3,4-tetrahydroquinolin-1-yl)ethan-1-one |
304676-35-5 |
98% |
Y3269134 |
[1,1':4',1'':4'',1''':4''',1'''':4'''',1'''''-Sexiphenyl]-4,4'''''-dicarboxylic acid |
1246015-46-2 |
98% |
Y1235398 |
Apalutamide D4 |
1638885-65-0 |
99% |
Y1266070 |
(R)-VU 6008667 |
2097818-14-7 |
99% |
Y1265959 |
UCT943 |
1450666-80-4 |
98% |
Y3234719 |
1H-Pyrazole, 3-(difluoromethyl)-1-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)- |
2197909-48-9 |
95% |
Y3267143 |
4-Methyl-2-(methylthio)phenylboronic acid |
1451392-51-0 |
95% |
Y3245774 |
MDM2-IN-1 |
1410737-09-5 |
99% |
Y3240781 |
5-(4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl)benzene-1,3-dicarboxylic acid |
307512-66-9 |
95% |
Y1291246 |
4,4'-(2,2-Diphenylethene-1,1-diyl)bis(bromobenzene) |
859315-37-0 |
98% |
Y1265948 |
2,4,6-Tris(4-ethynylphenyl)-1,3,5-triazine |
425629-22-7 |
98% |
Y1265986 |
4'-(Pyridin-4-yl)-[1,1'-biphenyl]-3,5-dicarboxylic acid |
2022152-71-0 |
98% |
Y3316202 |
2',5'-Bis(hexyloxy)-[1,1':4',1''-terphenyl]-4,4''-dicarbaldehyde |
474974-24-8 |
98% |
Y1265957 |
9,10-Bis(pyridin-4-ylethynyl)anthracene |
596130-35-7 |
97% |
Y1235348 |
PF-06263276 |
1421502-62-6 |
99% |
Y1265981 |
[1,1':4',1''-Terphenyl]-2',4,4'',5'-tetracarboxylic acid |
115101-93-4 |
98% |
Y1266069 |
[1,1':4',1'':2'',1''':4''',1''''-Quinquephenyl]-4,4''''-dicarboxylic acid, 4'',5''-bis(4'-carboxy[1,1'-biphenyl]-4-yl)- |
1643112-46-2 |
95% |
Y1265949 |
4,4'-((2,5-Dimethoxy-1,4-phenylene)bis(ethyne-2,1-diyl))dibenzaldehyde |
1190963-83-7 |
97% |
Y3268755 |
methyl3-bromo-2-chloroisonicotinate |
1214385-62-2 |
95% |
Y3261570 |
Methyl 4-(piperidin-2-yl)benzoate hydrochloride |
863769-42-0 |
95% |
Y3315701 |
Ludaconitine |
82144-72-7 |
98% |
Y3286334 |
Fructo-oligosaccharide DP9/GF8 |
143625-74-5 |
95% |
Y3272172 |
3-Amino-4-bromothiophene-2-carboxylic acid |
215927-34-7 |
98% |
Y1266027 |
(2E)-2-(1H-1,3-benzodiazol-2-yl)-3-(3-hydroxy-4-methoxyphenyl)prop-2-enenitrile |
305849-88-1 |
98% |
Y3271572 |
5-Chloro-2-(4-fluorophenyl)pyridine |
1214327-65-7 |
95% |
Y3297263 |
FKBP12 PROTAC RC32 |
2375555-66-9 |
98% |
Y3291335 |
N-(5,7-dimethyl-1,3-benzothiazol-2-yl)-1-(4-fluorobenzenesulfonyl)piperidine-4-carboxamide |
923509-20-0 |
98% |
Y3258877 |
N-(1,3-benzothiazol-2-yl)-2-{[3-(2-methoxyphenyl)-4-oxo-3H,4H,6H,7H-thieno[3,2-d]pyrimidin-2-yl]sulfanyl}acetamide |
362501-82-4 |
98% |
Y3287422 |
N-(4,7-dimethyl-1,3-benzothiazol-2-yl)-1-(4-fluorobenzenesulfonyl)piperidine-4-carboxamide |
923417-09-8 |
99% |
Y3249558 |
4-(1,1-difluoroethyl)aniline hydrochloride |
2408975-58-4 |
95% |
Y3260555 |
3,3-difluoro-4-(2-fluorophenyl)-1-(4-methoxyphenyl)azetidin-2-one |
328109-39-3 |
95% |
Y3307982 |
1-(9H-carbazol-9-yl)-3-{[(4-methylphenyl)methyl]amino}propan-2-ol |
1345853-50-0 |
99% |
Y3307623 |
NUCC-390 |
1060524-97-1 |
98% |
Y3289966 |
MC-DM1 |
1375089-56-7 |
95% |
Y3293301 |
MC-SN38 |
1473403-87-0 |
98% |
Y3258504 |
Racemic, Trans-1-Cyclopropyl-cyclopropyl-2-boronic acid pinacol ester |
350031-03-7 |
95% |
Y3315761 |
N-Benzyl hydroxymedetomidine ( 1-(1-Benzyl-1H-imidazol-5-yl)-1-(2,3-dimethylphenyl)ethanol.) |
2250243-44-6 |
95% |
Y1344362 |
Osimertinib D6 |
1638281-44-3 |
99% |
Y3265116 |
3-bromo-2-methoxypyridine-4-carbaldehyde |
1227605-71-1 |
95% |
Y3267222 |
Licochalcone E |
864232-34-8 |
98% |
Y1235357 |
Galegine hydrochloride |
2368870-39-5 |
97% |
Y3263672 |
Oleuropeinic acid |
96382-90-0 |
98% |
Y3314416 |
Neochebulagic acid |
28196-46-5 |
90% |
Y1337980 |
3-Methylenepiperidin-2-one |
68074-14-6 |
96% |
Y3259758 |
Palbociclib-propargyl |
2366269-23-8 |
95% |
Y1333877 |
Thalidomide-PEG2-C2-NH2 TFA |
2097509-36-7 |
98% |
Y3263691 |
3-Fluoro-5-cyclopropylpyridine |
1414870-74-8 |
95% |
Y3267790 |
QPX7728-OH disodium |
2170848-99-2 |
99% |
Y1235423 |
[1,1':4',1'':4'',1''':3''',1'''':4'''',1''''':4''''',1''''''-Septiphenyl]-3,3'''''',5,5''''''-tetracarboxylic acid, 5'''-(3'',5''-dicarboxy[1,1':4',1''-terphenyl]-4-yl)- |
1333127-74-4 |
97% |
Y1235442 |
[1,1-Biphenyl]-3,5-dicarboxylic acid, 4-[bis(3,5-dicarboxy[1,1-biphenyl]-4-yl)amino]- |
1347748-59-7 |
97% |
Y1235443 |
Thalidomide-NH-PEG2-C2-NH-Boc |
2097509-40-3 |
98% |
Y3101997 |
3-Methyl-5-(methylthio)benzaldehyde |
1289089-92-4 |
95% |
Y1235359 |
Macropa-NH2 hydrochloride |
2443966-86-5 |
99% |
Y3101917 |
N-tert-butyl-2,6-dichloropyridine-4-carboxamide |
1152504-12-5 |
95% |
Y3287578 |
Methyl 3,3-Dibromo-oxindole-7-carboxylate |
898747-43-8 |
95% |
Y3318640 |
2-Methyl-2-(3-nitro-phenyl)-propionic acid methyl ester |
103797-22-4 |
95% |
Y3254953 |
1-Methyl-1H-imidazole-4-sulfonic acid methylamide |
410545-45-8 |
95% |
Y3262768 |
4-Fluoro-3-(methylthio)benzyl alcohol |
1449008-21-2 |
95% |
Y3270750 |
3-Chloro-2-fluoro-4-methoxy-benzaldehyde |
208193-49-1 |
95% |
Y3264865 |
5-Chloromethyl-2-phenoxy-pyridine |
57958-55-1 |
93% |
Y3297839 |
2-Bromo-3-trifluoromethyl-benzenesulfonyl chloride |
55695-21-1 |
95% |
Y3257029 |
3-Bromomethyl-5-fluoro-benzo[b]thiophene |
17512-59-3 |
95% |
Y3316356 |
4-Bromo-3-iodo-5-methyl-1H-indazole |
1427502-42-8 |
97% |
Y1235445 |
4,4'-(3',4',5',6'-Tetrakis(4-(pyridin-4-yl)phenyl)-[1,1':2',1''-terphenyl]-4,4''-diyl)dipyridine |
591215-23-5 |
98% |
Y3266104 |
4-Bromo-3-(trifluoromethyl)-1,1'-biphenyl |
876758-59-7 |
95% |
Y3102248 |
2,6-Difluoro-3-(methylthio)benzaldehyde |
1428234-72-3 |
95% |
Y3258479 |
H-D-Phe-Pip-Arg-pNA hydrochloride |
160192-34-7 |
99% |
Y3102144 |
Methyl 5-bromopyridazine-3-carboxylate |
1256826-30-8 |
95% |
Y3286682 |
3-Methanesulfonyl-5-trifluoromethylbenzoic ac id |
53985-43-6 |
95% |